{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:12:28Z","timestamp":1790010748081,"version":"4.0.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100022113","name":"University of Health and Allied Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022113","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["MRC\/AMR\/MR\/S004815\/1"],"award-info":[{"award-number":["MRC\/AMR\/MR\/S004815\/1"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation Medical Research Council","doi-asserted-by":"publisher","award":["MRC\/AMR\/MR\/S004815\/1"],"award-info":[{"award-number":["MRC\/AMR\/MR\/S004815\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner Fresenius Foundation","doi-asserted-by":"publisher","award":["2018_HA10SP"],"award-info":[{"award-number":["2018_HA10SP"]}],"id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJID Regions"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ijregi.2026.100926","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T23:21:16Z","timestamp":1779751276000},"page":"100926","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["World Health Organization bacterial priority pathogens in skin and soft tissue infections: prevalence, antimicrobial resistance, and risk factors in Mwanza, Tanzania"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4178-3254","authenticated-orcid":false,"given":"Vitus","family":"Silago","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Oravcova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen E.","family":"Mshana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike","family":"Claus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremiah","family":"Seni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijregi.2026.100926_bib0001","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1179\/2047773215Y.0000000030","article-title":"Antimicrobial resistance: a global multifaceted phenomenon","volume":"109","author":"Prestinaci","year":"2015","journal-title":"Pathog Glob Health"},{"key":"10.1016\/j.ijregi.2026.100926_sbref0002","series-title":"WHO publishes list of bacteria for which new antibiotics are urgently needed Geneva, Switzerland","year":"2017"},{"key":"10.1016\/j.ijregi.2026.100926_bib0003","unstructured":"World Health Organization. WHO bacterial priority pathogens list. Bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance; 2024. Geneva, Switzerland. (accessed 1 June 2024). https:\/\/www.who.int\/publications\/i\/item\/9789240093461"},{"key":"10.1016\/j.ijregi.2026.100926_bib0004","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.actatropica.2018.07.007","article-title":"Causative agents and antimicrobial resistance patterns of human skin and soft tissue infections in Bagamoyo, Tanzania","volume":"186","author":"Kazimoto","year":"2018","journal-title":"Acta Trop"},{"key":"10.1016\/j.ijregi.2026.100926_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-016-2082-1","article-title":"Antimicrobial resistance pattern: a report of microbiological cultures at a tertiary hospital in Tanzania","volume":"16","author":"Moremi","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijregi.2026.100926_bib0006","unstructured":"World Health Organization. Global action plan on antimicrobial resistance [press release] Geneva, Switzerland: World Health Organization; January 1, 2016. p. 2016. (accessed 15 May 2019). https:\/\/www.who.int\/publications\/i\/item\/9789241509763"},{"key":"10.1016\/j.ijregi.2026.100926_bib0007","unstructured":"URT. The national action plan on antimicrobial resistance 2017-2022. United Republic of Tanzania. 2017. (accessed 10 March 2023). https:\/\/www.who.int\/publications\/m\/item\/united-republic-of-tanzania-second-national-action-plan-on-antimicrobial-resistance"},{"key":"10.1016\/j.ijregi.2026.100926_sbref0008","series-title":"Referral, consultant, and University Teaching Hospital: Bugando Medical Centre","year":"2024"},{"key":"10.1016\/j.ijregi.2026.100926_sbref0009","series-title":"Population Size in Tanzania","year":"2022"},{"key":"10.1016\/j.ijregi.2026.100926_bib0010","unstructured":"MoHT. Standard treatment guidelines and national essential medicines list for Tanzania Mainland. 6th ed. Dodoma, Tanzania: Ministry of Health, Tanzania; 2021. p. 491\u2013493. (accessed 10 October 2021). https:\/\/www.moh.go.tz\/storage\/app\/uploads\/public\/663\/c8f\/ceb\/663c8fceb418d132695047.pdf"},{"key":"10.1016\/j.ijregi.2026.100926_bib0011","series-title":"Koneman's color atlas and textbook of diagnostic microbiology","author":"Procop","year":"2020"},{"key":"10.1016\/j.ijregi.2026.100926_bib0012","unstructured":"Hudzicki J. Kirby-Bauer disk diffusion susceptibility test protocol, 15. Washington, DC: American society for microbiology; 2009. p. 1\u201323. (accessed 16 February 2018). https:\/\/asm.org\/getattachment\/2594ce26-bd44-47f6-8287-0657aa9185ad\/kirby-bauer-disc-diffusion-susceptibility-test-protocol-pdf.pdf"},{"key":"10.1016\/j.ijregi.2026.100926_bib0013","series-title":"Performance standards for antimicrobial susceptibility testing. 29th ed. CLSI supplement M100","year":"2019"},{"key":"10.1016\/j.ijregi.2026.100926_bib0014","series-title":"Performance standards for antimicrobial susceptibility testing. 32nd ed. CLSI supplement M100","year":"2022"},{"key":"10.1016\/j.ijregi.2026.100926_bib0015","series-title":"Performance standards for antimicrobial susceptibility testing. 35th ed. CLSI supplement M100","year":"2025"},{"key":"10.1016\/j.ijregi.2026.100926_bib0016","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1128\/JB.183.12.3770-3783.2001","article-title":"Bacterial diversity in human subgingival plaque","volume":"183","author":"Paster","year":"2001","journal-title":"J Bacteriol"},{"key":"10.1016\/j.ijregi.2026.100926_bib0017","unstructured":"EUCAST. Breakpoint tables for interpretation of MICs and zone diameters. version 13.0. Central Hospital. V\u00e4xj\u00f6, Sweden: The European Committee on Antimicrobial Susceptibility Testing; 2023. p. 351 85. (accessed 15 January 2023). https:\/\/www.eucast.org\/news-detail\/the-130-versions-of-breakpoints-dosing-and-qc-2023-published\/"},{"key":"10.1016\/j.ijregi.2026.100926_bib0018","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1007\/s11999-015-4142-z","article-title":"Premature therapeutic antimicrobial treatments can compromise the diagnosis of late periprosthetic joint infection","volume":"473","author":"Shahi","year":"2015","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.ijregi.2026.100926_bib0019","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1007\/s11999-010-1338-0","article-title":"Prior use of antimicrobial therapy is a risk factor for culture-negative prosthetic joint infection","volume":"468","author":"Malekzadeh","year":"2010","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.ijregi.2026.100926_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2482-11-21","article-title":"Predictors of surgical site infections among patients undergoing major surgery at Bugando Medical Centre in Northwestern Tanzania","volume":"11","author":"Mawalla","year":"2011","journal-title":"BMC Surg"},{"key":"10.1016\/j.ijregi.2026.100926_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2047-2994-3-25","article-title":"Incidence and predictors of surgical site infections following caesarean sections at Bugando Medical Centre, Mwanza, Tanzania","volume":"3","author":"Mpogoro","year":"2014","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.ijregi.2026.100926_bib0022","doi-asserted-by":"crossref","first-page":"113","DOI":"10.24248\/eahrj.v6i1.686","article-title":"Predictors of surgical site infections among patients undergoing open urological surgery at a tertiary hospital, Tanzania: a cross sectional study","volume":"6","author":"Kibwana","year":"2022","journal-title":"East Afr Health Res J"},{"issue":"Suppl. 2","key":"10.1016\/j.ijregi.2026.100926_bib0023","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1093\/cid\/civ528","article-title":"Skin and soft-tissue infections: a critical review and the role of telavancin in their treatment","volume":"61","author":"Cardona","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijregi.2026.100926_bib0024","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00326-22","article-title":"Characteristics and outcomes of patients with Delftia acidovorans infections: a retrospective cohort study","volume":"10","author":"H\u00f8jgaard","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.ijregi.2026.100926_bib0025","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5419874","article-title":"Multidrug-resistant bacteria: their mechanism of action and prophylaxis","volume":"2022","author":"Bharadwaj","year":"2022","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.ijregi.2026.100926_bib0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/6644185","article-title":"High level of multidrug-resistant Gram-negative pathogens causing burn wound infections in hospitalized children in Dar es Salaam, Tanzania","volume":"2021","author":"Kabanangi","year":"2021","journal-title":"Int J Microbiol"},{"key":"10.1016\/j.ijregi.2026.100926_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2024\/5548434","article-title":"Antimicrobial susceptibility profiles of Klebsiella pneumoniae Strains collected from clinical samples in a hospital in Southern Italy","volume":"2024","author":"Santella","year":"2024","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"10.1016\/j.ijregi.2026.100926_bib0028","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ijantimicag.2006.10.015","article-title":"Differential expression of blaSHV related to susceptibility to ampicillin in Klebsiella pneumoniae","volume":"29","author":"Fu","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijregi.2026.100926_bib0029","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.3390\/antibiotics10101249","article-title":"National antibiotics utilization trends for human use in Tanzania from 2010 to 2016 inferred from Tanzania medicines and medical devices authority importation data","volume":"10","author":"Sangeda","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.ijregi.2026.100926_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41182-020-00214-x","article-title":"The first confirmed case of COVID-19 in Tanzania: recommendations based on lesson learned from China","volume":"48","author":"Tarimo","year":"2020","journal-title":"Trop Med Health"},{"key":"10.1016\/j.ijregi.2026.100926_bib0031","first-page":"277","article-title":"The antibiotic resistance crisis: part 1: Causes and threats","volume":"40","author":"Ventola","year":"2015","journal-title":"P T"},{"key":"10.1016\/j.ijregi.2026.100926_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2024.107208","article-title":"Epidemiology and antimicrobial resistance trends of pathogens causing urinary tract infections in Mwanza, Tanzania: a comparative study during and after the implementation of the National Action Plan on Antimicrobial Resistance (2017-2022)","volume":"147","author":"Silago","year":"2024","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijregi.2026.100926_bib0033","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1038\/s41598-024-53543-w","article-title":"Improving diagnostic accuracy of blood culture-positive cases in a cancer center via an antimicrobial stewardship program and infectious disease consultations","volume":"14","author":"Itoh","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijregi.2026.100926_bib0034","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s12879-021-05999-8","article-title":"Improved detection of microbiological pathogens: role of partner and non-governmental organizations","volume":"21","author":"Owusu","year":"2021","journal-title":"BMC Infect Dis"}],"container-title":["IJID Regions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772707626000895?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772707626000895?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:41:22Z","timestamp":1790008882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772707626000895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":34,"alternative-id":["S2772707626000895"],"URL":"https:\/\/doi.org\/10.1016\/j.ijregi.2026.100926","relation":{},"ISSN":["2772-7076"],"issn-type":[{"value":"2772-7076","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"World Health Organization bacterial priority pathogens in skin and soft tissue infections: prevalence, antimicrobial resistance, and risk factors in Mwanza, Tanzania","name":"articletitle","label":"Article Title"},{"value":"IJID Regions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijregi.2026.100926","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"100926"}}